Abcellera Biologics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Abcellera Biologics
Tip: Access up to 7 years of quarterly data
All positions including Abcellera Biologics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Abcellera Biologics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $3.4M | 601k | 5.71 |
| 2023-09-30 | $1.2M | 259k | 4.60 |
| 2023-06-30 | $2.7M | 420k | 6.46 |
| 2023-03-31 | $2.6M | 351k | 7.54 |
| 2022-12-31 | $4.7M | 465k | 10.13 |
| 2022-06-30 | $2.5M | 235k | 10.65 |
| 2022-03-31 | $1.1M | 113k | 9.75 |
| 2021-12-31 | $1.9M | 135k | 14.30 |
| 2021-09-30 | $376k | 19k | 20.06 |
| 2021-03-31 | $942k | 28k | 33.97 |